Atazanavir Accord 200 mg hard capsules Ireland - English - HPRA (Health Products Regulatory Authority)

atazanavir accord 200 mg hard capsules

accord healthcare ireland ltd. - atazanavir sulphate - capsule, hard - 200 milligram(s) - protease inhibitors; atazanavir

ATAZANAVIR TEVA 200 MG Israel - English - Ministry of Health

atazanavir teva 200 mg

teva israel ltd - atazanavir as sulfate - capsules - atazanavir as sulfate 200 mg - atazanavir - atazanavir teva ® is indicated in combination with other antiretroviral agents for for the treatment of hiv-1 infection.

Atazanavir Accord 300 mg hard capsules Ireland - English - HPRA (Health Products Regulatory Authority)

atazanavir accord 300 mg hard capsules

accord healthcare ireland ltd. - atazanavir sulfate - capsule, hard - 300 milligram(s) - atazanavir

Atazanavir Teva 200 mg Capsules, hard Ireland - English - HPRA (Health Products Regulatory Authority)

atazanavir teva 200 mg capsules, hard

teva b.v. - atazanavir sulfate - capsule, hard - 200 milligram(s) - protease inhibitors; atazanavir - protease inhibitor - atazanavir teva capsules, co-administered with low dose ritonavir, are indicated for the treatment of hiv-1 infected adults and paediatric patients 6 years of age and older in combination with other antiretroviral medicinal products. based on available virological and clinical data from adult patients, no benefit is expected in patients with strains resistant to multiple protease inhibitors ( 4 pi mutations). there are very limited data available from children aged 6 to less than 18 years

Atazanavir Rowex 200 mg Capsules hard Ireland - English - HPRA (Health Products Regulatory Authority)

atazanavir rowex 200 mg capsules hard

rowex ltd - atazanavir sulfate - capsule, hard - 200 milligram(s) - atazanavir

ATAZANAVIR TEVA 300 MG Israel - English - Ministry of Health

atazanavir teva 300 mg

teva israel ltd - atazanavir as sulfate - capsules - atazanavir as sulfate 300 mg - atazanavir - atazanavir teva ® is indicated in combination with other antiretroviral agents for for the treatment of hiv-1 infection.

ATAZANAVIR capsule, gelatin coated United States - English - NLM (National Library of Medicine)

atazanavir capsule, gelatin coated

greenstone llc - atazanavir sulfate (unii: 4mt4vie29p) (atazanavir - unii:qzu4h47a3s) - atazanavir 150 mg - atazanavir is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection for patients 3 months and older weighing at least 5 kg. limitations of use: atazanavir is contraindicated: table 6 displays drugs that are contraindicated with atazanavir. drug class drugs within class that are contraindicated with atazanavir clinical comment alpha 1-adrenoreceptor antagonist alfuzosin potential for increased alfuzosin concentrations, which can result in hypotension. antimycobacterials rifampin rifampin substantially decreases plasma concentrations of atazanavir, which may result in loss of therapeutic effect and development of resistance. antineoplastics irinotecan atazanavir inhibits ugt1a1 and may interfere with the metabolism of irinotecan, resulting in increased irinotecan toxicities. antipsychotics lurasidone potential for serious and/or life-threatening reactions if atazanavir is coadministered with ritonavir. pimozide potential for serious and/or life-threatening reactions such

REYATAZ 200 MG Israel - English - Ministry of Health

reyataz 200 mg

bristol - myers squibb, israel - atazanavir as sulfate - capsules - atazanavir as sulfate 200 mg - atazanavir - atazanavir - reyataz is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.

Atazanavir Mylan European Union - English - EMA (European Medicines Agency)

atazanavir mylan

mylan pharmaceuticals limited - atazanavir (as sulfate) - hiv infections - antivirals for systemic use - atazanavir mylan, co-administered with low dose ritonavir, is indicated for the treatment of hiv 1 infected adults and paediatric patients 6 years of age and older in combination with other antiretroviral medicinal products.based on available virological and clinical data from adult patients, no benefit is expected in patients with strains resistant to multiple protease inhibitors (≥ 4 pi mutations). there are very limited data available from children aged 6 to less than 18 years.the choice of atazanavir mylan in treatment experienced adult and paediatric patients should be based on individual viral resistance testing and the patient’s treatment history.

Atazanavir Teva Capsules Hard 200mg Malta - English - Medicines Authority

atazanavir teva capsules hard 200mg

teva b.v. swensweg 5, 2031 ga haarlem, netherlands - atazanavir sulfate - hard capsule - atazanavir sulfate 200 mg - antivirals for systemic use